Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 362.74B | 370.31B | 359.46B | 336.91B | 282.09B | 273.61B |
Gross Profit | 115.11B | 118.94B | 103.82B | 95.20B | 75.79B | 74.56B |
EBITDA | 38.28B | 40.25B | 37.91B | 39.70B | 26.52B | 24.78B |
Net Income | 18.22B | 20.28B | 13.02B | 16.23B | 5.87B | 2.15B |
Balance Sheet | ||||||
Total Assets | 306.31B | 313.34B | 316.82B | 299.36B | 280.81B | 264.33B |
Cash, Cash Equivalents and Short-Term Investments | 49.32B | 48.60B | 57.87B | 56.19B | 48.71B | 59.64B |
Total Debt | 53.43B | 50.37B | 57.30B | 62.48B | 69.84B | 75.59B |
Total Liabilities | 176.32B | 181.93B | 195.60B | 195.63B | 196.85B | 195.80B |
Stockholders Equity | 124.19B | 125.10B | 114.80B | 98.81B | 79.50B | 64.64B |
Cash Flow | ||||||
Free Cash Flow | 17.87B | 18.74B | 12.16B | 10.79B | -8.90B | 21.92B |
Operating Cash Flow | 30.14B | 31.45B | 33.17B | 26.61B | 7.06B | 35.83B |
Investing Cash Flow | -20.85B | -21.55B | -16.06B | -7.33B | -9.80B | -11.80B |
Financing Cash Flow | -12.15B | -18.79B | -19.35B | -14.03B | -11.27B | -5.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $27.45T | 23.62 | 14.70% | 0.50% | -3.84% | 18.55% | |
73 Outperform | ¥4.04T | 11.00 | 7.89% | 2.25% | -4.14% | 16.99% | |
70 Outperform | €174.43B | 9.32 | 15.38% | 1.41% | 0.31% | 23.47% | |
69 Neutral | $281.17B | 49.29 | 2.56% | 3.71% | -4.66% | -61.05% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | $2.85T | 113.80 | 0.81% | 2.48% | -1.48% | -75.67% | |
57 Neutral | ¥93.04B | 26.80 | ― | 2.35% | 0.31% | -50.17% |